Over my 40 years with MS I’ve been treated with four disease-modifying therapies: Avonex, Tysabri, Aubagio and Lemtrada. Sometimes a wash-out period was needed – sometimes not – but being treated with one never seemed to impact my treatment with another. Here’s a report on a study about making the switch to one of my quartet of treatments.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.